The new funds from the private placement will finance the company until 2030. | Read More in Front – Globes
Entera Bio raises $275m for Phase III osteoporosis drug trial
Recent Posts
The Jerusalem Post
Sharaa’s Israel comments signal shift toward security arrangements, not peace deals – analysis
July 27, 2026Iran, Turkey seeking regime change in Israel via foreign interference, Likud MK warns to ‘Post’
July 27, 2026AI singularity is here, OpenAI’s Sam Altman claims: Technion expert says that he may be right
July 27, 2026- July 27, 2026
YnetNews
‘There’s no single component that, if destroyed, would make Iran’s nuclear program disappear’
July 27, 2026No press, no departure details: Netanyahu departs for Trump meeting
July 27, 2026‘We had a friend in need’: how Israel quietly helped India turn the tide in a Himalayan war
July 27, 2026Trump on Iran talks: ‘Either it goes fast or not at all’
July 27, 2026
Arutz Sheva
‘When the wicked perish’: Haredi extremists celebrate death of IDF integration advocateJuly 27, 2026
Trump: ‘We have disagreements with Netanyahu, but our positions on Iran are close’July 27, 2026
‘Jew Derangement Syndrome’ | Trump shares scathing post slamming Tucker CarlsonJuly 27, 2026
Two years in waiting: Rom Braslavski completes Torah started during his captivityJuly 27, 2026
JTA
- July 27, 2026
Jewish education’s brightest stars take center stage
July 27, 2026- July 27, 2026
Recognition of Armenian Genocide belongs to Israel, not to one government – opinion
July 27, 2026Boy George releases pro-Israel anthem ‘We Will Dance Again’ honoring Oct. 7 victims
July 27, 2026